Literature DB >> 30504358

How do we diagnose immune thrombocytopenia in 2018?

John G Kelton1,2, John R Vrbensky3, Donald M Arnold1,4,5.   

Abstract

In this report, we will review the various clinical and laboratory approaches to diagnosing immune thrombocytopenia (ITP), with a focus on its laboratory diagnosis. We will also summarize the results from a number of laboratories that have applied techniques to detect anti-platelet autoantibodies as diagnostic tests for ITP. Although there is considerable variability in methods among laboratories, there is general agreement that platelet autoantibody testing has a high specificity but low sensitivity. This suggests several possibilities: (1) the ideal test for ITP has yet to be developed, (2) current test methods need to be improved, or (3) ITP is the clinical expression of a variety of thrombocytopenic disorders with different underlying mechanisms. Even the clinical diagnosis of ITP is complex, and experienced clinicians do not always agree on whether a particular patient has ITP. Improvements in the diagnostic approach to ITP are necessary to improve the management of this disorder.
© 2018 by The American Society of Hematology. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30504358      PMCID: PMC6245958          DOI: 10.1182/asheducation-2018.1.561

Source DB:  PubMed          Journal:  Hematology Am Soc Hematol Educ Program        ISSN: 1520-4383


  51 in total

Review 1.  Risk of thrombosis in patients with primary immune thrombocytopenia and antiphospholipid antibodies: A systematic review and meta-analysis.

Authors:  Guillaume Moulis; Alexandra Audemard-Verger; Laurent Arnaud; Cécile Luxembourger; François Montastruc; Amelia Maria Gaman; Elisabet Svenungsson; Marco Ruggeri; Matthieu Mahévas; Mathieu Gerfaud-Valentin; Andres Brainsky; Marc Michel; Bertrand Godeau; Maryse Lapeyre-Mestre; Laurent Sailler
Journal:  Autoimmun Rev       Date:  2015-12-19       Impact factor: 9.754

2.  Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group.

Authors:  Francesco Rodeghiero; Roberto Stasi; Terry Gernsheimer; Marc Michel; Drew Provan; Donald M Arnold; James B Bussel; Douglas B Cines; Beng H Chong; Nichola Cooper; Bertrand Godeau; Klaus Lechner; Maria Gabriella Mazzucconi; Robert McMillan; Miguel A Sanz; Paul Imbach; Victor Blanchette; Thomas Kühne; Marco Ruggeri; James N George
Journal:  Blood       Date:  2008-11-12       Impact factor: 22.113

3.  Correlation between immature platelet fraction and reticulated platelets. Usefulness in the etiology diagnosis of thrombocytopenia.

Authors:  Issac Pons; Manuel Monteagudo; Gianni Lucchetti; Luz Muñoz; Granada Perea; Isabel Colomina; Joaquim Guiu; Joaquima Obiols
Journal:  Eur J Haematol       Date:  2010-05-08       Impact factor: 2.997

4.  The effect of rituximab on anti-platelet autoantibody levels in patients with immune thrombocytopenia.

Authors:  Donald M Arnold; John R Vrbensky; Nadia Karim; James W Smith; Yang Liu; Nikola Ivetic; John G Kelton; Ishac Nazy
Journal:  Br J Haematol       Date:  2017-04-25       Impact factor: 6.998

5.  Difficulties in establishing the diagnosis of immune thrombocytopenia: An agreement study.

Authors:  Mary Salib; Robert Clayden; Rumi Clare; Grace Wang; Theodore E Warkentin; Mark A Crowther; Wendy Lim; Ishac Nazi; John G Kelton; Donald M Arnold
Journal:  Am J Hematol       Date:  2016-06-01       Impact factor: 10.047

6.  Autoimmune thrombocytopenia: detection of platelet autoantibodies with the suspension immunofluorescence test.

Authors:  A E von dem Borne; F M Helmerhorst; E F van Leeuwen; H G Pegels; E von Riesz; C P Engelfriet
Journal:  Br J Haematol       Date:  1980-06       Impact factor: 6.998

7.  Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura.

Authors:  W J HARRINGTON; V MINNICH; J W HOLLINGSWORTH; C V MOORE
Journal:  J Lab Clin Med       Date:  1951-07

8.  Relative efficacy of steroid therapy in immune thrombocytopenia mediated by anti-platelet GPIIbIIIa versus GPIbα antibodies.

Authors:  Qingshu Zeng; Lingyan Zhu; Lili Tao; Jing Bao; Mingzhen Yang; Elisa K Simpson; Conglei Li; Dianne E van der Wal; Pingguo Chen; Christopher M Spring; Mingli Wang; Lingjie Zhang; Changgeng Ruan; Ming Hou; Ruixiang Xia; Heyu Ni
Journal:  Am J Hematol       Date:  2011-12-03       Impact factor: 10.047

9.  Autoantibodies to thrombopoietin and the thrombopoietin receptor in patients with immune thrombocytopenia.

Authors:  Ishac Nazy; John G Kelton; Jane C Moore; Rumi Clare; Peter Horsewood; James W Smith; Nikola Ivetic; Vanessa D'Souza; Na Li; Donald M Arnold
Journal:  Br J Haematol       Date:  2018-03-13       Impact factor: 6.998

10.  T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura.

Authors:  Bob Olsson; Per-Ola Andersson; Margareta Jernås; Stefan Jacobsson; Björn Carlsson; Lena M S Carlsson; Hans Wadenvik
Journal:  Nat Med       Date:  2003-08-24       Impact factor: 53.440

View more
  5 in total

1.  Clinical Epidemiology, Treatment Outcome and Mortality Rate of Newly Diagnosed Immune Thrombocytopenia in Adult Multicentre Study in Malaysia.

Authors:  Roszymah Hamzah; Nurasyikin Yusof; Nor Rafeah Tumian; Suria Abdul Aziz; Nur Syahida Mohammad Basri; Tze Shin Leong; Kim Wah Ho; Veena Selvaratnam; Sen Mui Tan; Siti Afiqah Muhamad Jamil
Journal:  J Blood Med       Date:  2022-06-21

2.  The Development of Immune Thrombocytopenia Due to COVID-19 Presenting as Menorrhagia.

Authors:  Sasmith R Menakuru; Adelina Priscu; Vijaypal S Dhillon; Ahmed Salih
Journal:  Cureus       Date:  2022-04-15

3.  Regorafenib-induced exacerbation of chronic immune thrombocytopenic purpura in remission: A case report.

Authors:  Shiro Kimbara; Yoshinori Imamura; Kimikazu Yakushijin; Ako Higashime; Taiji Koyama; Yoshimi Fujishima; Yohei Funakoshi; Masanori Toyoda; Naomi Kiyota; Hiroshi Matsuoka; Hironobu Minami
Journal:  Mol Clin Oncol       Date:  2020-12-16

Review 4.  Primary Immune Thrombocytopenia and Essential Thrombocythemia: So Different and yet Somehow Similar-Cases Series and a Review of the Literature.

Authors:  Marta Sobas; Maria Podolak-Dawidziak; Krzysztof Lewandowski; Michał Bator; Tomasz Wróbel
Journal:  Int J Mol Sci       Date:  2021-10-09       Impact factor: 5.923

Review 5.  Steroid-Induced Diabetes Ketoacidosis in an Immune Thrombocytopenia Patient: A Case Report and Literature Review.

Authors:  Ziyad Alakkas; Ohud A Alzaedi; Suresh Shivapp Somannavar; Abdulaziz Alfaifi
Journal:  Am J Case Rep       Date:  2020-05-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.